Skip to main content
. 2022 Mar 18;14(3):675. doi: 10.3390/pharmaceutics14030675

Figure 5.

Figure 5

Activation of the four PL–cyclosporine prodrugs following incubation with healthy (left) vs. diseased (right) cBBMVs. Average ± SD; n = 4. PL, phospholipid; cBBMV, colonic brush border membrane vesicles.